Platelet-rich plasma and plantar fasciitis

Sports Med Arthrosc Rev. 2013 Dec;21(4):220-4. doi: 10.1097/JSA.0b013e318297fa8d.


Plantar fasciitis is the most common cause of heel pain and can prove difficult to treat in its most chronic and severe forms. Advanced cases of plantar fasciitis are often associated with ankle stiffness, heel spurs, and other conditions and can lead to extensive physical disability and financial loss. Most available traditional treatments, including orthoses, nonsteroidal anti-inflammatory drugs, and steroid injections have a paucity of supportive clinical evidence. More invasive treatments, ranging from corticosteroid and botulinum-A toxin injections to shockwave therapy and plantar fasciotomy, have demonstrated varying clinical success in severe cases but carry the potential for serious complication and permanent disability. Platelet-rich plasma has recently been demonstrated to be helpful in managing chronic severe tendinopathies when other techniques have failed. This review examines the pathophysiology, diagnostic options, nonoperative treatment modalities, and surgical options currently used for plantar fasciitis. It also focuses on the clinical rationale and available evidence for using autologous platelet-rich plasma to treat severe refractory chronic plantar fasciitis.

Publication types

  • Review

MeSH terms

  • Chronic Disease
  • Combined Modality Therapy
  • Fasciitis, Plantar / diagnosis
  • Fasciitis, Plantar / physiopathology
  • Fasciitis, Plantar / therapy*
  • Humans
  • Magnetic Resonance Imaging
  • Medical History Taking
  • Physical Examination
  • Platelet-Rich Plasma*
  • Treatment Outcome